A single lumbar IMU paired with a nonlinear analytics pipeline can detect gait reorganization during intensive stroke rehabilitation imperceptible to standard clinical measures, in a proof-of-concept case series of three people with chronic stroke.
Key Findings
Results
All three participants showed a 52-62% increase in Wolf's Lyapunov exponent during Stroke Boot Camp (SBC) Week 2, the most consistent nonlinear change across participants.
Participants were three individuals with chronic stroke monitored across the two-week SBC intensive interdisciplinary rehabilitation program.
The abstract describes this Lyapunov change as 'most consistent across participants'.
Sample size was n = 3, so this is a case series and not a controlled trial.
Results
Entropy responses were heterogeneous across participants, but SampEn and RCMSE showed greater longitudinal sensitivity than conventional spatiotemporal metrics.
The nonlinear panel included sample entropy, multi-scale entropy variants, Lyapunov exponents and recurrence quantification analysis metrics (24 features in total).
Participant-specific entropy patterns differed rather than following a single shared direction.
Comparison was against linear spatiotemporal gait parameters extracted by the same pipeline.
Conclusions
The nonlinear gait changes were detected by the IMU during intensive rehabilitation and were described as imperceptible to standard clinical measures.
A standardized clinical battery (FMA, BBS, FGA, 10 MWT, 6 MWT) was administered at each of the five sessions.
The authors conclude that gait reorganization was captured by the IMU pipeline but not apparent in the standard clinical assessments.
Methods
A single lower-back IMU enabled continuous multi-day free-living gait monitoring across five sessions from one week pre-intervention to three months post-intervention.
The device was a DynaPort McRoberts IMU mounted on the lower back.
Monitoring spanned the pre-intervention week, the two-week SBC program and follow-up out to three months.
The study was designed to evaluate feasibility and longitudinal sensitivity of IMU-derived digital biomarkers.
Methods
A validated Python-based pipeline was used to process free-living data into linear and nonlinear gait biomarkers.
It implemented Mobilise-D gait sequence detection.
It used wavelet-based heel strike and toe-off identification.
It extracted linear spatiotemporal parameters alongside a 24-feature nonlinear panel including sample entropy, multi-scale entropy variants, Lyapunov exponents and recurrence quantification analysis.
Conclusions
The authors position the work as a reproducible methodological foundation for larger controlled trials.
The study is described as a proof-of-concept pilot with n = 3.
Conventional clinical assessments are limited to supervised environments and do not capture continuous real-world motor behavior, motivating the free-living approach.
What This Means
This small pilot study followed three people with long-term effects of stroke through a two-week intensive rehabilitation program. Each wore a small motion sensor on the lower back during everyday life, from a week before the program until three months after. The researchers analyzed not only standard walking measures such as speed and step timing but also measures of how complex and variable the walking pattern is over time.
All three participants showed a 52-62% increase in one measure of walking dynamics (the Wolf Lyapunov exponent) during the second week of the program. Other complexity measures, such as entropy, changed differently from person to person, but they tended to pick up changes over time better than conventional walking measures. Standard clinical tests, given at each session, did not reveal these changes.
This research suggests that a single wearable sensor worn at home could track subtle changes in how people walk during stroke rehabilitation, beyond what clinic tests show. However, with only three participants and no control group, the findings are preliminary. They mainly show that the approach is feasible and justify larger controlled studies to understand what the changes mean for recovery.